
Clinical stage firm ImmunoCellular Therapeutics has announced the appointment of Andrew Gengos as president and chief executive and member of …
Early stage trials of a new treatment for the brain cancer glioblastoma multiforme have shown promise. ICT-107 is being developed …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

